Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2313 | 2218 | 42.5 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
87 | 25794 | HERPES SIMPLEX VIRUS//VARICELLA ZOSTER VIRUS//HERPES ZOSTER |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLYCOPROTEIN D | Author keyword | 29 | 49% | 2% | 43 |
2 | NECTIN 1 | Author keyword | 21 | 64% | 1% | 21 |
3 | SECT MICROBIOL VIROL | Address | 17 | 44% | 1% | 30 |
4 | GLYCOPROTEIN K | Author keyword | 14 | 100% | 0% | 7 |
5 | HSV VACCINE | Author keyword | 13 | 80% | 0% | 8 |
6 | HVEA | Author keyword | 9 | 83% | 0% | 5 |
7 | GLYCOPROTEIN B | Author keyword | 7 | 21% | 1% | 28 |
8 | CANC BIOL IMMUNOL | Address | 6 | 80% | 0% | 4 |
9 | CANCEROL IMMUNOL | Address | 6 | 71% | 0% | 5 |
10 | HVEC | Author keyword | 6 | 71% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLYCOPROTEIN D | 29 | 49% | 2% | 43 | Search GLYCOPROTEIN+D | Search GLYCOPROTEIN+D |
2 | NECTIN 1 | 21 | 64% | 1% | 21 | Search NECTIN+1 | Search NECTIN+1 |
3 | GLYCOPROTEIN K | 14 | 100% | 0% | 7 | Search GLYCOPROTEIN+K | Search GLYCOPROTEIN+K |
4 | HSV VACCINE | 13 | 80% | 0% | 8 | Search HSV+VACCINE | Search HSV+VACCINE |
5 | HVEA | 9 | 83% | 0% | 5 | Search HVEA | Search HVEA |
6 | GLYCOPROTEIN B | 7 | 21% | 1% | 28 | Search GLYCOPROTEIN+B | Search GLYCOPROTEIN+B |
7 | HVEC | 6 | 71% | 0% | 5 | Search HVEC | Search HVEC |
8 | HSV 2 | 6 | 13% | 2% | 41 | Search HSV+2 | Search HSV+2 |
9 | GLYCOPROTEIN C | 6 | 31% | 1% | 15 | Search GLYCOPROTEIN+C | Search GLYCOPROTEIN+C |
10 | UL53 GENE | 4 | 67% | 0% | 4 | Search UL53+GENE | Search UL53+GENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GB GLYCOPROTEIN | 153 | 98% | 2% | 41 |
2 | POLIOVIRUS RECEPTOR | 117 | 53% | 7% | 155 |
3 | GLYCOPROTEIN D | 114 | 43% | 9% | 206 |
4 | 3 O SULFATED HEPARAN SULFATE | 79 | 79% | 2% | 50 |
5 | GD RECEPTOR | 68 | 100% | 1% | 22 |
6 | ENTRY MEDIATOR | 54 | 64% | 2% | 53 |
7 | HERPES SIMPLEX VIRUS 1 GH | 53 | 95% | 1% | 18 |
8 | ALPHAHERPESVIRUS ENTRY | 47 | 86% | 1% | 24 |
9 | SYN PHENOTYPE | 45 | 90% | 1% | 19 |
10 | COMPLEMENT COMPONENT C3B | 34 | 93% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Fusing structure and function: a structural view of the herpesvirus entry machinery | 2011 | 115 | 119 | 78% |
Herpes simplex virus: receptors and ligands for cell entry | 2004 | 270 | 75 | 71% |
Herpes Virus Fusion and Entry: A Story with Many Characters | 2012 | 53 | 189 | 75% |
Entry of herpesviruses into mammalian cells | 2008 | 136 | 152 | 64% |
Herpesvirus entry: an update | 2003 | 316 | 47 | 72% |
The multipartite system that mediates entry of herpes simplex virus into the cell | 2007 | 59 | 74 | 86% |
Three classes of cell surface receptors for alphaherpesvirus entry | 2000 | 262 | 57 | 53% |
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry | 2009 | 57 | 47 | 77% |
HSV-2 Vaccine: Current Status and Insight into Factors for Developing an Efficient Vaccine | 2014 | 8 | 107 | 55% |
The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells | 2000 | 145 | 73 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT MICROBIOL VIROL | 17 | 44% | 1.4% | 30 |
2 | CANC BIOL IMMUNOL | 6 | 80% | 0.2% | 4 |
3 | CANCEROL IMMUNOL | 6 | 71% | 0.2% | 5 |
4 | INTERUNIV RIC PEPTIDI BIOATTIVI | 5 | 32% | 0.5% | 12 |
5 | MOL TUMOR VIROL | 4 | 17% | 0.9% | 20 |
6 | MED MICROBIOL IMMUNOL 303 E CHICAGO AVE | 3 | 100% | 0.1% | 3 |
7 | ANIM EXPT DIS MODEL | 3 | 33% | 0.4% | 8 |
8 | AVIAN ZOONOSES | 2 | 38% | 0.2% | 5 |
9 | DENT MED ORAL HLTH | 2 | 67% | 0.1% | 2 |
10 | VACCINES BASIC | 2 | 50% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000158017 | NEUROBIOL VACCINE DEV//HERPES SIMPLEX KERATITIS//HERPETIC STROMAL KERATITIS |
2 | 0.0000153510 | US3//VIRUS ASSEMBLY GRP//VIROL SHOWA KU |
3 | 0.0000100602 | GENITAL HERPES//NEONATAL HERPES//HSV 2 |
4 | 0.0000088653 | SIMIAN VARICELLA VIRUS//VARICELLA ZOSTER VIRUS//VZV |
5 | 0.0000084604 | ICP8//UL9//ALKALINE NUCLEASE |
6 | 0.0000084205 | MARJORIE B KOVLER VIRAL ONCOL S//ICP27//ICP0 |
7 | 0.0000083317 | AUJESZKYS DISEASE//PSEUDORABIES VIRUS//PSEUDORABIES |
8 | 0.0000080968 | FLUOROSCEIN ISOTHIOCYANATE//INFLUENZA A H1N12009//LUCIFER YELLOW CARBOHYDRAZIDE |
9 | 0.0000077468 | HERPES B VIRUS//CERCOPITHECINE HERPESVIRUS 1//B VIRUS |
10 | 0.0000072006 | EQUINE HERPESVIRUS 1//EHV 1//EQUINE VIROL |